The Effects of Aromatase Inhibitors and Growth Hormone Therapy on Early Puberty and Height A Randomized Control Trial (RCT) Study Proposal

Article Sidebar

PDF
Published: Aug 5, 2024
Keywords:
early puberty growth hormonal therapy aromatase inibitors puberty delay height growth clinical trial

Main Article Content

Nazanin Roughani
a:1:{s:5:"en_US";s:13:"HSCI student ";}

Abstract

This study investigates the effectiveness of growth hormone (GH) therapy and aromatase inhibitors (AIs) in managing early puberty and promoting height growth in children aged 6-9 years. Participants are randomized into GH therapy, AIs, or placebo groups. The study's primary outcomes include assessing the delay in puberty onset and measuring height growth through standardized methodologies. The research aims to shed light on these treatments' potential benefits and comparative efficacy in addressing precocious puberty.

Article Details

How to Cite
Roughani, N. (2024). The Effects of Aromatase Inhibitors and Growth Hormone Therapy on Early Puberty and Height: A Randomized Control Trial (RCT) Study Proposal. SFU Health Sciences Undergraduate Journal, (3). Retrieved from https://journals.lib.sfu.ca/index.php/healthsciences/article/view/6503
Issue
No. 3 (2024)
Section
Article
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All content in this journal is published under a Creative Commons Attribution Non-Commercial license. Content can be freely shared, distributed, modified, and reused, providing credit is given to the original author, and the work is not used in any commercial context.